BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9303209)

  • 1. Plasmodium vivax: epitope mapping of monoclonal antibodies against the N-terminal region of the merozoite surface protein 1.
    Levitus G; Mertens F; Kirchgatter K; Oliveira SG; del Portillo HA
    Behring Inst Mitt; 1997 Mar; (99):107-11. PubMed ID: 9303209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
    Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
    Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
    J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
    Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
    Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
    Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
    Soares IS; Oliveira SG; Souza JM; Rodrigues MM
    Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.
    Udhayakumar V; Anyona D; Kariuki S; Shi YP; Bloland PB; Branch OH; Weiss W; Nahlen BL; Kaslow DC; Lal AA
    J Immunol; 1995 Jun; 154(11):6022-30. PubMed ID: 7538540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
    Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
    Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
    Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V
    Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of monoclonal antibodies against a 19-kD recombinant Plasmodium vivax MSP1 for detection of P. vivax malaria in Turkey.
    Ak M; Babaoğlu A; Dağci H; Türk M; Bayram S; Ertabaklar H; Ozcel MA; Uner A; Charoenvit Y; Kumar S; Hoffman SL
    Hybrid Hybridomics; 2004 Apr; 23(2):133-6. PubMed ID: 15165487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria.
    Soares IS; Levitus G; Souza JM; Del Portillo HA; Rodrigues MM
    Infect Immun; 1997 May; 65(5):1606-14. PubMed ID: 9125537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.
    Arévalo-Herrera M; Roggero MA; Gonzalez JM; Vergara J; Corradin G; López JA; Herrera S
    Ann Trop Med Parasitol; 1998 Jul; 92(5):539-51. PubMed ID: 9797827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax.
    Levitus G; Mertens F; Speranca MA; Camargo LM; Ferreira MU; del Portillo HA
    Am J Trop Med Hyg; 1994 Jul; 51(1):68-76. PubMed ID: 8059917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation.
    Perez-Leal O; Sierra AY; Barrero CA; Moncada C; Martinez P; Cortes J; Lopez Y; Torres E; Salazar LM; Patarroyo MA
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1393-9. PubMed ID: 15504368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and immunological properties of a viral hybrid particle expressing the Plasmodium vivax merozoite surface protein 1 C-terminal region.
    Wunderlich G; del Portillo HA
    Mol Med; 2000 Mar; 6(3):238-45. PubMed ID: 10965497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
    Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
    Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
    Bargieri DY; Rosa DS; Braga CJ; Carvalho BO; Costa FT; Espíndola NM; Vaz AJ; Soares IS; Ferreira LC; Rodrigues MM
    Vaccine; 2008 Nov; 26(48):6132-42. PubMed ID: 18804504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human IgG responses against the N-terminal region of the Merozoite Surface Protein 1 of Plasmodium vivax.
    del Portillo HA; Levitus G; Camargo LM; Ferreira MU; Mertens F
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():77-84. PubMed ID: 1343729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
    Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
    Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.